{"cik":1671858,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"ARS Pharmaceuticals, Inc.","units":{"USD":[{"end":"2024-12-31","val":0,"accn":"0001193125-25-273111","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-10"},{"end":"2024-12-31","val":0,"accn":"0001193125-26-097478","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-09","frame":"CY2024Q4I"},{"end":"2025-09-30","val":96229000,"accn":"0001193125-25-273111","fy":2025,"fp":"Q3","form":"10-Q","filed":"2025-11-10","frame":"CY2025Q3I"},{"end":"2025-12-31","val":96374000,"accn":"0001193125-26-097478","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-09"},{"end":"2025-12-31","val":96374000,"accn":"0001193125-26-225142","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15"},{"end":"2025-12-31","val":96374000,"accn":"0001193125-26-349140","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13","frame":"CY2025Q4I"},{"end":"2026-03-31","val":96522000,"accn":"0001193125-26-225142","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-15","frame":"CY2026Q1I"},{"end":"2026-06-30","val":96676000,"accn":"0001193125-26-349140","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-13","frame":"CY2026Q2I"}]}}